|
| Saturday, March 16, 2013 |
|
|
IBN Engineered Artificial Human Livers for Drug Testing and Discovery |
| IBN researchers have now made it possible for companies to predict the toxicity of new drugs earlier, potentially speeding up the drug development process and reducing the cost of manufacturing. more info >> |
|
| Friday, March 8, 2013 |
|
|
A*STAR Scientists Discover "Switch" Critical to Wound Healing |
| Scientists from A*STAR's Institute of Medical Biology (IMB) have identified a molecular "switch" that controls the migration of skin cells necessary for wounds to close and heal. more info >> |
|
| Thursday, February 21, 2013 |
|
|
IBN Creates Unlimited Source of Human Kidney Cells |
| Researchers at the Institute of Bioengineering and Nanotechnology (IBN) have successfully generated human kidney cells from human embryonic stem cells in vitro. more info >> |
|
| Friday, February 8, 2013 |
|
|
A*STAR Scientists Make Groundbreaking Discovery of Cell Nucleus Structure Crucial to Understanding Diseases |
| Scientists from Singapore and Germany have identified that the proteins lamin A (Lmna) and lamin B receptor (Lbr) are essential for holding silent genes in their correct position at the edge of the nucleus, in the form of heterochromatin. more info >> |
|
| Friday, December 14, 2012 |
|
|
Gross Expenditure on R&D Hits New High of S$7.4 Billion in 2011 |
| Singapore's gross expenditure on R&D (GERD)1 recorded a new high of S$7.4 billion in 2011, according to the National Survey of R&D, 2011, produced by the Agency for Science, Technology and Research (A*STAR). It was a 14.8% growth from S$6.5 billion in 2010. more info >> |
|
|
Genome Institute of Singapore and Fluidigm Establish Asia's First Single-cell Genomics Research Center |
| The Genome Institute of Singapore (GIS), an institute under the umbrella of the A*STAR, and Fluidigm Corporation (NASDAQ:FLDM) today announced the establishment of the first research center in Asia exclusively dedicated to accelerating the understanding of how individual cells work, and how diagnosis and treatment might be enhanced through insight derived from single cells. more info >> |
|
| Thursday, December 13, 2012 |
|
|
Singapore Scientists Identify New Biomarker for Cancer in Bone Marrow |
| Singapore scientists have identified FAIM, a molecule that typically prevents cell death, as a potential biomarker to identify an incurable form of cancer in the bone marrow. more info >> |
|
| Monday, December 3, 2012 |
|
|
Singapore Partners with UK in Conference to Advance Skin Research |
| More than 150 scientists from academia, industry and the clinical community in Singapore and the United Kingdom are gathering at Biopolis this week. more info >> |
|
| Thursday, November 29, 2012 |
|
|
Leading Big Data Company Appistry Joins Genome Institute of Singapore to Accelerate Genomics in Asia |
| The Agency for Science, Technology and Research's (A*STAR) Genome Institute of Singapore (GIS) today announced the launch of a research collaboration with Appistry, a leading US-based provider of high-performance computing and analytics for managing and storing "big data." more info >> |
|
| Wednesday, November 21, 2012 |
|
|
A*STAR Scientists Identify Potential Drug Target for Inflammatory Diseases Including Cancers |
| A*STAR scientists have identified the enzyme, telomerase, as a cause of chronic inflammation in human cancers. Chronic inflammation is now recognized as a key underlying cause for the development of many human cancers, autoimmune disorders, neurodegenerative diseases, and metabolic diseases such as diabetes. more info >> |
|
|
|
